Distribution of Inflammatory Mediators in Carotid and Femoral Plaques
Authors:
- Wei ZhouWZWei Zhou
- Hong ChaiHCHong Chai
- Richard DingRDRichard Ding
- Ho Yin Colin LamHLHo Yin Colin Lam
- 1 July 2010
- journal article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 211 (1) , 92-98
Abstract
Although atherosclerosis is a known systemic process, carotid and femoral atherosclerotic plaques are associated with distinctive complications and therapeutic outcomes. The purpose of this study was to evaluate inflammatory markers associated with carotid and femoral plaques. Carotid and femoral endarterectomy specimens were harvested from surgical patients. The carotid specimens were further sectioned into central, peripheral, and relatively normal regions. Expressions of matrix metalloproteinase (MMP)-2 and MMP-9 in carotid and femoral specimens were compared and the distributions of MMP-2, MMP-9, and CD40 within the carotid specimens were further analyzed. Messenger RNA (mRNA) levels were measured with real-time polymerase chain reaction and proteins with ELISA assay and Western blot. Despite no significant difference in the MMP-2 mRNA levels between carotid and femoral specimens, the common femoral specimens had significantly lower MMP-2 protein production and higher MMP-9 mRNA and protein expressions than those of the carotid specimens (p = 0.015, p = 0.03, and p = 0.034, respectively). Among carotid specimens, MMP-2 mRNA level was significantly lower in the central region (p < 0.01) and consistent with the distribution pattern of MMP-2 proteins. Interestingly, despite significantly lower MMP-9 mRNA expression in the central region of carotid plaques, active MMP-9 protein level was significantly higher. CD40 mRNA and protein levels were also higher in the central region. Immunohistochemistry analyses showed substantially increased macrophages and CD40 in the central region of the carotid plaques. This study emphasizes that femoral and carotid plaques are distinct entities and that distribution of inflammatory molecular markers varied within these advanced atherosclerotic plaques. Additional analyses are warranted.Keywords
This publication has 13 references indexed in Scilit:
- Echolucent femoral plaques entail higher risk of echolucent carotid plaques and a more severe inflammatory profile in peripheral arterial diseaseJournal of Vascular Surgery, 2009
- Circulating matrix metalloproteinase 9 levels in relation to sampling methods, femoral and carotid atherosclerosisJournal of Internal Medicine, 2008
- Quantitation and Localization of Matrix Metalloproteinases and Their Inhibitors in Human Carotid Endarterectomy TissuesArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Lesional Overexpression of Matrix Metalloproteinase-9 Promotes Intraplaque Hemorrhage in Advanced Lesions But Not at Earlier Stages of AtherogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Matrix Metalloproteinase 2 Is Associated With Stable and Matrix Metalloproteinases 8 and 9 With Vulnerable Carotid Atherosclerotic LesionsStroke, 2006
- Prevalence of and Risk Factors for Peripheral Arterial Disease in the United StatesCirculation, 2004
- Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bedAtherosclerosis, 2003
- Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization?Cardiovascular Research, 1999
- Reduction of atherosclerosis in mice by inhibition of CD40 signallingNature, 1998
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994